Curosurf is a drug used for the treatment of (premature) newborns with (a risk of) respiratory distress syndrome (RDS). A cause of RDS can be a lack of surfactant production in the lungs. Curosurf contains Poractant alfa, a natural surfactant that works in the same way as the body’s own surfactant.
We want to point out that medication should always be determined in consultation with the attending physician. For information on treatment, consult your doctor and/or pharmacist.